ALK Gene Rearrangement Testing in Non-Small Cell Lung Carcinoma by ThinPrep-FISH

被引：0
|
作者：
Mince, E. C. [1 ]
Portier, B. P. [1 ]
Wang, Z. [1 ]
Brainard, J. [1 ]
Farver, C. [1 ]
Feng, Y. [1 ]
Ma, P. C. [1 ]
Arrossi, V. [1 ]
Pennel, N. [1 ]
Tubbs, R. R. [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1914
引用
收藏
页码：460A / 460A
页数：1
相关论文
共 50 条
  • [31] FISH and IHC Discordance in ALK Rearranged Non-Small Cell Lung Cancer
    Kapoor, A.
    Noronha, V.
    Joshi, A.
    Patil, V.
    Kaushal, R.
    Mahajan, A.
    Janu, A.
    Prabhash, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1900 - S1900
  • [32] Percentage of ALK Rearrangement as a Response Predictor in Non-Small Cell Lung Cancer Treatment
    Oliveira, M.
    Natal, R.
    Costa, J.
    Gomes, R.
    Amaral, A.
    Ferreira, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1076 - S1077
  • [33] Development of a novel ALK rearrangement screening test for non-small cell lung cancers
    Chen, Yi-Lin
    Chen, Wan-Li
    Cheng, Yi-Chia
    Lin, Ming-Ching
    Yang, Shu-Ching
    Tsai, Hung-Wen
    Lin, Chien-Chung
    Su, Wu-Chou
    Chow, Nan-Haw
    Ho, Chung-Liang
    PLOS ONE, 2021, 16 (09):
  • [34] An activating ALK gene mutation in ALK IHC-positive/FISH-negative non-small cell lung cancer
    Togashi, Yosuke
    Mizuuchi, Hiroshi
    Sakai, Kazuko
    Banno, Eri
    Hayashi, Hidetoshi
    de Velasco, Marco
    Fujita, Yoshihiko
    Tomida, Shuta
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    ANNALS OF ONCOLOGY, 2015, 26 : 73 - 73
  • [35] Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement
    Gil, Michal
    Chmielewska, Izabela
    Krawczyk, Pawel
    Nizinski, Przemyslaw
    Strzemski, Maciej
    Milanowski, Janusz
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 18 (03): : 190 - 196
  • [36] CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer
    Zhang, Meiling
    Wang, Qian
    Ding, Yan
    Wang, Guoqun
    Chu, Yunqian
    He, Xiang
    Wu, Xue
    Shao, Yang W.
    Lu, Kaihua
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1792 - 1797
  • [37] Next-generation sequencing discordant ALK-rearrangement in non-small cell lung carcinoma with ovarian metastases
    Tan, Charles Jeffrey Lay
    Li, Rubi K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1460 - S1460
  • [38] Immunohistochemistry May Not Be a Reliable Screening Tool for Identification of ALK Rearrangement (ALKR) in Non-Small Cell Lung Carcinoma (NSCLC)
    Conklin, C. M. J.
    Craddock, K. J.
    Have, C.
    Tsao, M.
    Couture, C.
    Ionescu, D. N.
    LABORATORY INVESTIGATION, 2012, 92 : 475A - 475A
  • [39] Immunohistochemistry May Not Be a Reliable Screening Tool for Identification of ALK Rearrangement (ALKR) in Non-Small Cell Lung Carcinoma (NSCLC)
    Conklin, C. M. J.
    Craddock, K. J.
    Have, C.
    Tsao, M.
    Couture, C.
    Ionescu, D. N.
    MODERN PATHOLOGY, 2012, 25 : 475A - 475A
  • [40] A case report of metastatic bilateral ovarian cancer due to non-small cell lung cancer with ALK gene rearrangement
    Liu, Zhitong
    Liu, Bo
    Li, Changzhong
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 151 - 153
12345